HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Microinvasive breast carcinoma with extensive involvement of level III axillary lymph nodes: a case report.

Abstract
A 44-year-old woman presented with a right huge axillary mass. Both mammography and ultrasonography revealed a primary cancer of 2.8 cm maximum diameter in the right breast and metastases in the axillary lymph nodes, both being confirmed by aspiration cytology as ductal carcinoma. Right standard radical mastectomy with level III axillary lymph node dissection was carried out. Pathologically, the tumor was diagnosed as ductal carcinoma in situ with microinvasion (DCISM), histologic grade 3. The area of stromal invasion measured 1 mm at its widest point. Sixteen of the 17 resected axillary lymph nodes contained metastases, including six level III lymph nodes. Immunohistochemical studies of the tumor revealed overexpression of p53 protein, but not that of c-erbB-2 protein. The frequency of lymph node metastases from DCISM is reported to be very low. Therefore, the present case with extensive involvement of level III lymph nodes was unusual.
AuthorsK Fujii, T Fukutomi, H Tsuda, S Akashi-Tanaka, T Nanasawa, Y Kanai, Y Muramatsu
JournalJapanese journal of clinical oncology (Jpn J Clin Oncol) Vol. 28 Issue 1 Pg. 47-9 (Jan 1998) ISSN: 0368-2811 [Print] England
PMID9491142 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Tumor Suppressor Protein p53
  • Receptor, ErbB-2
Topics
  • Adult
  • Axilla
  • Breast Neoplasms (chemistry, pathology, surgery)
  • Carcinoma, Ductal, Breast (chemistry, secondary, surgery)
  • Female
  • Humans
  • Immunohistochemistry
  • Lymph Nodes (pathology)
  • Lymphatic Metastasis
  • Mastectomy, Radical
  • Neoplasm Invasiveness
  • Receptor, ErbB-2 (metabolism)
  • Tumor Suppressor Protein p53 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: